Press Releases on June 5, 2023 - EIN Presswire - Press Release Distribution Service

Published on June 5, 2023 - 12:00 GMT

InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference

DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors through the Program of All-inclusive Care for the Elderly ( …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman Sachs 44th Annual Global Healthcare Conference. Goldman …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on June 5, 2023 - 12:00 GMT

Aspira Women’s Health Appoints Dr. Winfred Parnell to its Board of Directors

AUSTIN, Texas, June 05, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Dr. …

Distribution channels: Companies ...

Published on June 5, 2023 - 12:00 GMT

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

SAN JOSE, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

Replimune Appoints Veleka R. Peeples-Dyer to its Board of Directors

WOBURN, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, today announced the appointment of …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

Mobiv Acquisition Corp Announces Extension of Deadline to Complete Business Combination

Newark, Delaware, June 05, 2023 (GLOBE NEWSWIRE) -- Mobiv Acquisition Corp (Nasdaq: MOBVU, MOBV, MOBVW) (the “Company”), a special purpose acquisition company, announced today that, on June 1, 2023, it notified the trustee of the Company’s trust account …

Distribution channels: Banking, Finance & Investment Industry, Environment ...

Published on June 5, 2023 - 12:00 GMT

NorthWestern Energy names Bleau LaFave vice president of asset management and business development

SIOUX FALLS, S.D. and BUTTE, Mont., June 05, 2023 (GLOBE NEWSWIRE) -- NorthWestern Corporation d/b/a NorthWestern Energy (Nasdaq: NWE) announces that Director of Long-Term Resources Bleau LaFave will succeed Curt Pohl as vice president of asset management …

Distribution channels: Companies, Energy Industry ...

Published on June 5, 2023 - 12:00 GMT

SecureTech Begins Testing on the Next Generation Top Kontrol Product Line

ROSEVILLE, Minn., June 05, 2023 (GLOBE NEWSWIRE) -- SecureTech Innovations, Inc. (OTC: SCTH), an emerging growth company that develops and markets cutting-edge security and safety devices, products, and technologies such as Top Kontrol and its early-stage …

Distribution channels: Automotive Industry, Media, Advertising & PR ...

Published on June 5, 2023 - 12:00 GMT

Support for Indigenous Businesses a Pathway to Healing and Growth

BURLINGTON, Ontario, June 05, 2023 (GLOBE NEWSWIRE) -- A strong majority of Canadians agree Indigenous businesses boost the Canadian economy (74%) and strengthen the country’s social fabric (76%). Sodexo’s third Indigenous Business Survey shows continued …

Distribution channels: Food & Beverage Industry, Science ...

Published on June 5, 2023 - 12:00 GMT

Une voie vers la guérison et la croissance: le soutien aux entreprises autochtones

MONTREAL, 05 juin 2023 (GLOBE NEWSWIRE) -- Une forte majorité de la population canadienne reconnaît que les entreprises autochtones ont stimulé l’économie canadienne (74 %) et renforcé le tissu social du pays (76 %). La troisième enquête de Sodexo sur les …

Distribution channels: Food & Beverage Industry, Science ...

Published on June 5, 2023 - 12:00 GMT

Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors

- No dose limiting toxicities observed with IMM-1-104 up to 320 mg once daily during the Phase 1a dose escalation portion of ongoing clinical study - - Phase 1b dose expansion has commenced; plan to enroll 21 additional patients at 240 mg or 320 mg daily - …

Distribution channels: Technology ...

Published on June 5, 2023 - 12:00 GMT

Navy Awards Kratos $46.7M Contract for Submarine Ballistic Missile Reentry Systems

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a Technology Company in the Defense, National Security and Global Markets, has been awarded a contract by the Naval Surface Warfare Center Dahlgren …

Distribution channels: Aviation & Aerospace Industry, Business & Economy ...

Published on June 5, 2023 - 12:00 GMT

Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth Hormone Receptor Antagonist (GHRA), AZP-3813, for ...

LYON, France and CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced the initiation of a Phase 1 clinical trial of the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on June 5, 2023 - 12:00 GMT

Amolyt Pharma lance l'essai clinique de phase 1 de l’AZP-3813, peptide antagoniste du récepteur de l'hormone de croissance pour le ...

LYON, France et CAMBRIDGE, Mass., 05 juin 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, société spécialisée dans le développement de peptides thérapeutiques ciblant les maladies endocriniennes rares, a annoncé ce jour le lancement d'un essai clinique de …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on June 5, 2023 - 12:00 GMT

NKGen Biotech Announces SNK01 Preclinical and Phase I/IIa Clinical Data Presented at the 2023 American Society of Clinical ...

SANTA ANA, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (NKGen), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK Natural Killer (NK) cell therapeutics, …

Distribution channels: Technology ...

Published on June 5, 2023 - 12:00 GMT

Digital Trade and Supply Chain Finance Provider Appoints Marina Narganes to Leadership Team

SINGAPORE, June 05, 2023 (GLOBE NEWSWIRE) -- Triterras Inc. (OTC Expert Market: TRIRF), a leading fintech company focused on trade and trade finance, announces the appointment of Marina Narganes as Head of Distribution & Sales Strategy. Ms. Narganes …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 5, 2023 - 12:00 GMT

Concrete Pumping Holdings Upsizes Asset-Based Lending Facility to $225 Million

PNC Joins Wells Fargo and JPMorgan in Lending Facility ABL Credit Agreement maturity extended for 5 years to June 1, 2028 DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider …

Distribution channels: Banking, Finance & Investment Industry ...

Published on June 5, 2023 - 12:00 GMT

Enterin Announces the Start of a First-in-Human Study of ENT-03 in Obesity and Type 2 Diabetes

PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today announced the start of a Phase 1a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting

100% of treated patients (n=8) to date have exceeded historical median progression-free survival, with two patients that received three doses remaining progression-free at 23.5 and 19.4 months, respectively. INB-200 continues to exhibit a manageable safety …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on June 5, 2023 - 12:00 GMT

NovelMed Phase I Clinical Trial Shows Inhibition of the Alternative Pathway and Preservation of the Classical Pathway – A Long-...

Phase I Clinical Trial in healthy subjects shows that NM3086 was safe and well tolerated at all doses (0.1 to 20 mg/kg) in six cohorts. Total AP inhibition was achieved through all cohorts and the duration of alternative pathway (AP) inhibition occurred in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...